Vaccines
The Centers for Disease Control and Prevention have approved COVID-19 vaccination for young children who are at least 6 months old, making roughly 20 million children in the United States under 5 years newly eligible for vaccination. This decision comes as COVID-19 cases are rising, and many parents are eager
Vaccines
Researchers at the University of North Carolina have made significant strides in the development of an oral prodrug of remdesivir, a medication used to treat COVID-19, which has shown promising results in in vitro and in vivo studies. The study, published in Science Translational Medicine, demonstrated the antiviral activity of
Vaccines
Hyperglycemia may significantly impact the immune response to COVID-19 vaccines in healthcare workers, with individuals having diabetes or impaired fasting glucose showing lower spike IgG antibody titers. The study, led by the National Center for Global Health and Medicine in Tokyo, Japan, suggests that hyperglycemia can alter the activation of
COVID-19
According to a recent prospective cohort study, hemodialysis patients exhibited a robust humoral response to a third dose of the BNT162b2 vaccine, although antibody levels declined significantly over time. The study found that antibody levels increased by an average of 112-fold two weeks post-booster and remained an average of 40-fold
COVID-19
American adults who haven't gotten vaccinated against COVID-19 may soon have another option, as FDA advisers voted to back a more traditional type of shot. Novavax's protein vaccine, made with conventional technology, has been available in several countries, but US clearance is a key hurdle for
COVID-19
A recent study published in the American Journal of Obstetrics & Gynecology MFM has shed light on the attitudes of pregnancy-capable healthcare workers toward COVID-19 vaccination. The research, conducted by Washington University, distributed a survey to 11,405 healthcare workers in the United States who were involved in patient care
COVID-19
India Exim Bank, along with the Japan Bank for International Cooperation (JBIC) and three Japanese private financial institutions, has concluded a USD 100 mn loan agreement to support the Indian healthcare sector in combating COVID-19. The facility will be utilized to finance vaccine manufacturers, pharmaceutical companies, and other related activities.
Vaccines
Rep. Rodolfo Ordanes, a senior citizen party-list member, has urged the Food and Drug Administration (FDA) to grant full approval to COVID-19 vaccines with emergency use authorization (EUA), citing a jump in vaccination rates due to the issuance of a certificate of product registration. Over 68 million Filipinos have been
Vaccines
The first set of volunteers has been dosed in an open-label study of AKS-452, a protein subunit COVID-19 vaccine booster developed by Akston Biosciences Corp. The Phase II booster study aims to investigate the immune response of up to 600 volunteers who have previously been vaccinated with EMA-registered vaccines from
COVID-19
Research at University Medical Center Mannheim has documented a case of acute myocarditis following mRNA COVID-19 vaccination. The study highlights the utility of cardiac magnetic resonance imaging (CMR) in the diagnosis and follow-up of patients with myocarditis. The patient, a 23-year-old male, presented with chest pain after receiving the second
Coronaviruses
Researchers at the University of Michigan published a study comparing the effectiveness of three COVID-19 vaccines - Pfizer-BioNTech, Moderna, and Johnson & Johnson-Janssen - in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 hospitalization during the pre- and post-Delta variant period. The study found that mRNA-based vaccines
Coronaviruses
Researchers at Thermo Fisher Scientific Inc. have made significant progress in the synthesis of various cap analogs, with potential applications in mRNA vaccine development for COVID-19. The study highlights the importance of chemically modified mRNA cap analogs in enhancing translational efficiency and binding affinity. The development of trinucleotide cap analogs
